| Product Code: ETC7631927 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market - Industry Life Cycle |
3.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market - Porter's Five Forces |
3.5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Cell Source, 2021 & 2031F |
3.6 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.9 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases and genetic disorders that can potentially be treated using induced pluripotent stem cells (iPSCs) |
4.2.2 Growing investment in research and development of iPSC technologies in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for iPSC research and therapy in Ireland |
4.3.2 Limited awareness and acceptance of iPSC therapies among healthcare providers and patients |
5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Trends |
6 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Types |
6.1 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Cell Source |
6.1.1 Overview and Analysis |
6.1.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Cell Source, 2021- 2031F |
6.1.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Skin Cells, 2021- 2031F |
6.1.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Blood Cells, 2021- 2031F |
6.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Human IPSCs, 2021- 2031F |
6.2.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Mouse IPSCs, 2021- 2031F |
6.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Consumables & Kits, 2021- 2031F |
6.3.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Applications |
6.4.1 Overview and Analysis |
6.4.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.4.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Regenerative Medicine, 2021- 2031F |
6.4.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Cellular Therapy, 2021- 2031F |
6.4.5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Toxicology Screening, 2021- 2031F |
6.4.6 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.4.7 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Development, 2021- 2031F |
6.4.8 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Biotechnology & Pharmaceutical Companies, 2021- 2031F |
6.5.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.5.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.5.5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Induced Pluripotent Stem Cells (iPSCs) Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Import-Export Trade Statistics |
7.1 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Export to Major Countries |
7.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Imports from Major Countries |
8 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Key Performance Indicators |
8.1 Research funding allocated to iPSC projects in Ireland |
8.2 Number of clinical trials involving iPSC therapies conducted in Ireland |
8.3 Number of partnerships between Irish research institutions and biopharmaceutical companies in the iPSC field |
9 Ireland Induced Pluripotent Stem Cells (iPSCs) Market - Opportunity Assessment |
9.1 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Cell Source, 2021 & 2031F |
9.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.4 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.5 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Induced Pluripotent Stem Cells (iPSCs) Market - Competitive Landscape |
10.1 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Revenue Share, By Companies, 2024 |
10.2 Ireland Induced Pluripotent Stem Cells (iPSCs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here